Annual Long Term Debt
$13.91 M
-$1.16 M-7.67%
31 December 2021
Summary:
Concert Pharmaceuticals annual long term debt is currently $13.91 million, with the most recent change of -$1.16 million (-7.67%) on 31 December 2021. During the last 3 years, it has fallen by -$1.16 million (-7.67%).CNCE Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$12.87 M
-$359.00 K-2.71%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly long term debt is currently $12.87 million, with the most recent change of -$359.00 thousand (-2.71%) on 30 September 2022.CNCE Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -7.7% | -9.5% |
| 5 y5 years | +100.0% | -20.5% |
CNCE Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -13.0% | -55.9% |
Concert Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $12.87 M(-2.7%) |
| June 2022 | - | $13.23 M(-2.6%) |
| Mar 2022 | - | $13.57 M(-2.4%) |
| Dec 2021 | $13.91 M(-7.7%) | $13.91 M(-2.1%) |
| Sept 2021 | - | $14.21 M(-2.0%) |
| June 2021 | - | $14.51 M(-1.9%) |
| Mar 2021 | - | $14.79 M(-1.8%) |
| Dec 2020 | $15.06 M(-5.8%) | $15.06 M(-1.6%) |
| Sept 2020 | - | $15.31 M(-1.5%) |
| June 2020 | - | $15.55 M(-1.5%) |
| Mar 2020 | - | $15.78 M(-1.4%) |
| Dec 2019 | $16.00 M | $16.00 M(-1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | $16.19 M(-1.1%) |
| June 2019 | - | $16.38 M(-1.1%) |
| Mar 2019 | - | $16.56 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| June 2017 | - | $29.19 M(+3666.2%) |
| Sept 2014 | - | $775.00 K(-74.3%) |
| June 2014 | - | $3.01 M(-42.1%) |
| Mar 2014 | - | $5.20 M(-29.2%) |
| Dec 2013 | $7.35 M(-52.6%) | $7.35 M(-22.2%) |
| Sept 2013 | - | $9.45 M(-39.0%) |
| Dec 2012 | $15.50 M(+92.6%) | $15.50 M |
| Dec 2011 | $8.05 M | - |
FAQ
- What is Concert Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual long term debt?
The current annual long term debt of CNCE is $13.91 M
What is the all time high annual long term debt for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual long term debt is $16.00 M
What is Concert Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of CNCE is $12.87 M
What is the all time high quarterly long term debt for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly long term debt is $29.19 M